000201192 001__ 201192
000201192 005__ 20240625095128.0
000201192 0247_ $$2doi$$a10.1016/j.jmb.2011.06.008
000201192 0247_ $$2ISSN$$a0022-2836
000201192 0247_ $$2ISSN$$a1089-8638
000201192 0247_ $$2WOS$$aWOS:000293938500014
000201192 037__ $$aFZJ-2015-03497
000201192 082__ $$a570
000201192 1001_ $$0P:(DE-Juel1)145921$$aRossetti, Giulia$$b0$$ufzj
000201192 245__ $$aCommon Structural Traits across Pathogenic Mutants of the Human Prion Protein and Their Implications for Familial Prion Diseases
000201192 260__ $$aAmsterdam [u.a.]$$bElsevier$$c2011
000201192 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1434026330_12156
000201192 3367_ $$2DataCite$$aOutput Types/Journal article
000201192 3367_ $$00$$2EndNote$$aJournal Article
000201192 3367_ $$2BibTeX$$aARTICLE
000201192 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000201192 3367_ $$2DRIVER$$aarticle
000201192 520__ $$aHuman (Hu) familial prion diseases are associated with about 40 point mutations of the gene coding for the prion protein (PrP). Most of the variants associated with these mutations are located in the globular domain of the protein. We performed 50 ns of molecular dynamics for each of these mutants to investigate their structure in aqueous solution. Overall, 1.6 μs of molecular dynamics data is presented. The calculations are based on the AMBER(parm99) force field, which has been shown to reproduce very accurately the structural features of the HuPrP wild type and a few variants for which experimental structural information is available. The variants present structural determinants different from those of wild-type HuPrP and the protective mutation HuPrP(E219K-129M). These include the loss of salt bridges in α2–α3 regions and the loss of π-stacking interactions in the β2–α2 loop. In addition, in the majority of the mutants, the α3 helix is more flexible and Y169 is more solvent exposed. The presence of similar traits in this large spectrum of mutations hints to a role of these fingerprints in their known disease-causing properties. Overall, the regions most affected by disease-linked mutations in terms of structure and/or flexibility are those involved in the pathogenic conversion to the scrapie form of the protein and in the interaction with cellular partners. These regions thus emerge as optimal targets for antibody- and ligand-binding studies.
000201192 536__ $$0G:(DE-HGF)POF2-899$$a899 - ohne Topic (POF2-899)$$cPOF2-899$$fPOF I$$x0
000201192 588__ $$aDataset connected to CrossRef, juser.fz-juelich.de
000201192 7001_ $$0P:(DE-HGF)0$$aCong, Xiaojing$$b1
000201192 7001_ $$0P:(DE-HGF)0$$aCaliandro, Rocco$$b2
000201192 7001_ $$0P:(DE-HGF)0$$aLegname, Giuseppe$$b3$$eCorresponding Author
000201192 7001_ $$0P:(DE-Juel1)145614$$aCarloni, Paolo$$b4$$ufzj
000201192 773__ $$0PERI:(DE-600)1355192-9$$a10.1016/j.jmb.2011.06.008$$gVol. 411, no. 3, p. 700 - 712$$n3$$p700 - 712$$tJournal of molecular biology$$v411$$x0022-2836$$y2011
000201192 8564_ $$uhttps://juser.fz-juelich.de/record/201192/files/1-s2.0-S0022283611006449-main.pdf$$yRestricted
000201192 8564_ $$uhttps://juser.fz-juelich.de/record/201192/files/1-s2.0-S0022283611006449-main.gif?subformat=icon$$xicon$$yRestricted
000201192 8564_ $$uhttps://juser.fz-juelich.de/record/201192/files/1-s2.0-S0022283611006449-main.jpg?subformat=icon-1440$$xicon-1440$$yRestricted
000201192 8564_ $$uhttps://juser.fz-juelich.de/record/201192/files/1-s2.0-S0022283611006449-main.jpg?subformat=icon-180$$xicon-180$$yRestricted
000201192 8564_ $$uhttps://juser.fz-juelich.de/record/201192/files/1-s2.0-S0022283611006449-main.jpg?subformat=icon-640$$xicon-640$$yRestricted
000201192 8564_ $$uhttps://juser.fz-juelich.de/record/201192/files/1-s2.0-S0022283611006449-main.pdf?subformat=pdfa$$xpdfa$$yRestricted
000201192 909CO $$ooai:juser.fz-juelich.de:201192$$pVDB
000201192 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR
000201192 915__ $$0StatID:(DE-HGF)0110$$2StatID$$aWoS$$bScience Citation Index
000201192 915__ $$0StatID:(DE-HGF)0111$$2StatID$$aWoS$$bScience Citation Index Expanded
000201192 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection
000201192 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bThomson Reuters Master Journal List
000201192 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS
000201192 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline
000201192 915__ $$0StatID:(DE-HGF)0310$$2StatID$$aDBCoverage$$bNCBI Molecular Biology Database
000201192 915__ $$0StatID:(DE-HGF)1030$$2StatID$$aDBCoverage$$bCurrent Contents - Life Sciences
000201192 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews
000201192 915__ $$0StatID:(DE-HGF)9900$$2StatID$$aIF <  5
000201192 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)145921$$aForschungszentrum Jülich GmbH$$b0$$kFZJ
000201192 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-HGF)0$$aForschungszentrum Jülich GmbH$$b1$$kFZJ
000201192 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)145614$$aForschungszentrum Jülich GmbH$$b4$$kFZJ
000201192 9132_ $$0G:(DE-HGF)POF3-899$$1G:(DE-HGF)POF3-890$$2G:(DE-HGF)POF3-800$$aDE-HGF$$bForschungsbereich Materie$$lForschungsbereich Materie$$vohne Topic$$x0
000201192 9131_ $$0G:(DE-HGF)POF2-899$$1G:(DE-HGF)POF2-890$$2G:(DE-HGF)POF2-800$$3G:(DE-HGF)POF2$$4G:(DE-HGF)POF$$aDE-HGF$$bProgrammungebundene Forschung$$lohne Programm$$vohne Topic$$x0
000201192 920__ $$lyes
000201192 9201_ $$0I:(DE-Juel1)GRS-20100316$$kGerman Research School for Simulation Sciences (GRS)$$lGRS$$x0
000201192 9201_ $$0I:(DE-Juel1)IAS-5-20120330$$kIAS-5$$lComputational Biomedicine$$x1
000201192 980__ $$ajournal
000201192 980__ $$aVDB
000201192 980__ $$aI:(DE-Juel1)GRS-20100316
000201192 980__ $$aI:(DE-Juel1)IAS-5-20120330
000201192 980__ $$aUNRESTRICTED
000201192 981__ $$aI:(DE-Juel1)INM-9-20140121
000201192 981__ $$aI:(DE-Juel1)IAS-5-20120330